Nuveen Asset Management, LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,250,411
+75.0%
142,702
+115.8%
0.00%
Q2 2023$1,285,704
+49791.5%
66,137
-27.2%
0.00%
-100.0%
Q1 2023$2,577
+13.2%
90,822
+16.5%
0.00%0.0%
Q4 2022$2,277
-99.9%
77,932
+20.0%
0.00%0.0%
Q3 2022$1,715,000
-43.2%
64,919
-4.4%
0.00%0.0%
Q2 2022$3,017,000
+46.7%
67,895
+61.5%
0.00%0.0%
Q1 2022$2,057,000
+7.8%
42,036
+1.0%
0.00%0.0%
Q4 2021$1,909,000
-28.2%
41,622
-12.6%
0.00%0.0%
Q3 2021$2,658,000
+27.8%
47,648
-1.9%
0.00%0.0%
Q2 2021$2,079,000
-5.6%
48,584
-7.9%
0.00%0.0%
Q1 2021$2,202,000
-8.1%
52,743
+2.5%
0.00%0.0%
Q4 2020$2,397,000
+13.6%
51,476
+3.6%
0.00%0.0%
Q3 2020$2,110,000
-13.1%
49,681
-1.8%
0.00%0.0%
Q2 2020$2,428,000
+19.1%
50,592
+14.2%
0.00%0.0%
Q1 2020$2,039,000
-21.4%
44,316
+2.6%
0.00%0.0%
Q4 2019$2,595,000
+4.9%
43,205
-1.2%
0.00%0.0%
Q3 2019$2,474,000
+0.8%
43,738
-0.7%
0.00%0.0%
Q2 2019$2,454,00044,0680.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 113,737$3,2270.98%
Smith, Graham & Co., Investment Advisors, LP 236,883$6,720,3710.82%
Capital Impact Advisors, LLC 13,607$386,0310.47%
TANG CAPITAL MANAGEMENT LLC 80,000$2,269,6000.34%
BRANDES INVESTMENT PARTNERS, LP 545,050$15,463,0690.33%
Watershed Asset Management, L.L.C. 9,496$269,4020.33%
SummerHaven Investment Management, LLC 18,178$515,7100.30%
Jackson Creek Investment Advisors LLC 25,164$7140.30%
Virtus Fund Advisers, LLC 1,117$31,6890.22%
Virtus Investment Advisers, Inc. 7,308$207,3280.14%
View complete list of EAGLE PHARMACEUTICALS INC shareholders